BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26220750)

  • 1. Use of the methacetin breath test to classify the risk of cirrhotic complications and mortality in patients evaluated/listed for liver transplantation.
    Stravitz RT; Reuben A; Mizrahi M; Lalazar G; Brown K; Gordon SC; Ilan Y; Sanyal A
    J Hepatol; 2015 Dec; 63(6):1345-51. PubMed ID: 26220750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between 13C-aminopyrine breath test and the MELD score and its long-term prognostic use in patients with cirrhosis.
    Giannini EG; Savarino V
    Dig Dis Sci; 2013 Oct; 58(10):3024-8. PubMed ID: 23817924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 13C-methacetin and 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis.
    Holtmeier J; Leuschner M; Schneider A; Leuschner U; Caspary WF; Braden B
    Scand J Gastroenterol; 2006 Nov; 41(11):1336-41. PubMed ID: 17060128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 13C-methacetin breath test correlates with clinical indices of liver disease severity in patients with primary biliary cirrhosis.
    Kochel-Jankowska A; Hartleb M; Jonderko K; Kaminska M; Kasicka-Jonderko A
    J Physiol Pharmacol; 2013 Feb; 64(1):27-33. PubMed ID: 23568968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation.
    Petrolati A; Festi D; De Berardinis G; Colaiocco-Ferrante L; Di Paolo D; Tisone G; Angelico M
    Aliment Pharmacol Ther; 2003 Oct; 18(8):785-90. PubMed ID: 14535871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of cirrhotic patients with blunt abdominal trauma: analysis of risk factor of postoperative death with the Model for End-Stage Liver Disease score.
    Lin BC; Fang JF; Wong YC; Hwang TL; Hsu YP
    Injury; 2012 Sep; 43(9):1457-61. PubMed ID: 21511254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
    Heuman DM; Abou-Assi SG; Habib A; Williams LM; Stravitz RT; Sanyal AJ; Fisher RA; Mihas AA
    Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of a 13C-methacetin breath test in evaluating hepatic injury in rats.
    Shirin H; Aeed H; Shalev T; Sorin V; Stavinski S; Shahmurov M; Ilan Y; Avni Y
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1762-8. PubMed ID: 19120861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [13C-methacetin breath test in chronic hepatitis C liver disease].
    Oliveira AC; Reber M; Lanzoni V; Ferraz ML; Parise ER
    Arq Gastroenterol; 2006; 43(1):41-4. PubMed ID: 16699617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the 13C-methacetin breath test for quantitative liver function testing.
    Klatt S; Taut C; Mayer D; Adler G; Beckh K
    Z Gastroenterol; 1997 Aug; 35(8):609-14. PubMed ID: 9297776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.
    Biselli M; Dall'Agata M; Gramenzi A; Gitto S; Liberati C; Brodosi L; Ravaioli M; Gambato M; Montalti R; Pinna AD; Burra P; Gerunda GE; Cillo U; Andreone P; Bernardi M
    Liver Int; 2015 Jan; 35(1):184-91. PubMed ID: 24650058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of the
    Fontana RJ; Stravitz RT; Durkalski V; Hanje J; Hameed B; Koch D; Reuben A; Ganger D; Olson J; Liou I; McGuire BM; Clasen K; Lee WM
    Hepatology; 2021 Aug; 74(2):961-972. PubMed ID: 33660316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infection.
    Braden B; Faust D; Sarrazin U; Zeuzem S; Dietrich CF; Caspary WF; Sarrazin C
    Aliment Pharmacol Ther; 2005 Jan; 21(2):179-85. PubMed ID: 15679768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation.
    Degré D; Bourgeois N; Boon N; Le Moine O; Louis H; Donckier V; El Nakadi I; Closset J; Lingier P; Vereerstraeten P; Gelin M; Adler M
    Transpl Int; 2004 Jan; 17(1):31-8. PubMed ID: 14745489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Metabolic Liver Function Tests: a Study on 711 Cirrhotic Patients.
    Lebossé F; Guillaud O; Forestier J; Ecochard M; Boillot O; Roman S; Mion F; Dumortier J
    J Gastrointestin Liver Dis; 2016 Sep; 25(3):337-43. PubMed ID: 27689198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
    Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
    Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could metabolic liver function tests predict mortality on waiting list for liver transplantation? A study on 560 patients.
    Ecochard M; Boillot O; Guillaud O; Roman S; Adham M; Mion F; Dumortier J
    Clin Transplant; 2011; 25(5):755-65. PubMed ID: 21158918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 13C-methacetin breath test as a quantitative liver function test in patients with chronic hepatitis C infection: continuous automatic molecular correlation spectroscopy compared to isotopic ratio mass spectrometry.
    Goetze O; Selzner N; Fruehauf H; Fried M; Gerlach T; Mullhaupt B
    Aliment Pharmacol Ther; 2007 Jul; 26(2):305-11. PubMed ID: 17593076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum sodium and hydration status predict transplant-free survival independent of MELD score in patients with cirrhosis.
    Mathur S; Gane EJ; McCall JL; Plank LD
    J Gastroenterol Hepatol; 2008 Feb; 23(2):239-43. PubMed ID: 17489965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.